Study finds new clues in understanding relapse in breast cancer

    Source: Xinhua| 2018-09-06 06:52:33|Editor: Yamei
    Video PlayerClose

    CHICAGO, Sept. 5 (Xinhua) -- A genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to U.S. researchers.

    The researchers at Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia analyzed tumor samples from more than 2,500 patients with estrogen receptor positive breast cancer, one of the most common forms of the disease.

    They found that although mutations in DDR1 and NF1 are rare, they are associated with early relapse, which makes them much more common in patients who unfortunately die from the disease.

    One unique element of the study was the age of the samples. Many were over 20 years old, allowing the researchers to know the full history of how the patients fared.

    The study also confirmed past work showing that relatively common mutations in genes called MAP3K1 and TP53 had opposite effects on tumor aggressiveness. Patients with MAP3K1 mutations did well, while those with TP53 mutations were likely to have a recurrence.

    The study has identified three genes, namely DDR1, PIK3R1 and NF1, with relatively uncommon mutations that were associated with cancer recurrence and spreading.

    "We would like to help doctors identify patients who are likely to do well versus those who are likely to have a recurrence," said first author Obi L. Griffith, an assistant professor of medicine and an assistant director of the McDonnell Genome Institute at Washington University School of Medicine.

    "Those with mutations that are associated with a good prognosis may need less intensive therapy than they might otherwise receive. But if a patient's tumor has mutations linked to high risk of relapse, it's useful to know that early so they can be treated with more aggressive therapies or even potential investigational therapies that could be targeted to their specific mutations," Griffith added.

    The researchers also pointed out the importance of continuing to sequence cancer genomes.

    More than 266,000 women in the United States are diagnosed with invasive breast cancer each year, according to the American Cancer Society, and about 70 percent of cases are estrogen receptor positive.

    The study was published on Tuesday in the journal Nature Communications.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011103261374478871
    主站蜘蛛池模板: 免费国产黄网站在线观看视频| 大胸美女放网站| 亚洲日本一区二区三区在线| 色一情一乱一伦一视频免费看| 国产精品线在线精品| 七次郎成人免费线路视频| 最近中文字幕免费mv视频7| 人人澡人人透人人爽| 色网站在线免费观看| 国产精品亚洲二区在线| xxxxx亚洲| 日本三级片网站| 国产精品久久久久9999赢消| 久久国产高清视频| 欧美日韩精品久久久久| 内射白浆一区二区在线观看| 韩国精品一区二区三区无码视频| 国产精品自在线拍国产电影| z0z0z0女人极品另类视频| 日本强伦姧人妻一区二区| 亚洲国产精品线在线观看| 男女真实无遮挡xx00动态图120秒| 国产乱妇乱子在线播视频播放网站| 14又嫩又紧水又多| 奇米小说首页图片区小说区| 丰满人体bbw| 日韩精品久久不卡中文字幕| 亚洲欧洲日本精品| 看黄软件免费看在线观看| 国产99视频精品免视看7| 91精品成人福利在线播放| 国产精品黄页在线播放免费 | 国产精品成年片在线观看| jizz性欧美2| 成人性开放大片| 久久人人妻人人做人人爽| 案件小说2阿龟婚俗验身| 亚洲欧美日韩在线观看| 男同精品视频免费观看网站| 啊灬啊灬啊灬快灬深久久| 香蕉97超级碰碰碰免费公|